Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
If DSIP doesn't produce noticeable results after a full protocol cycle, your provider may suggest alternative approaches or combinations
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test evaluates key variants in GIPR, and metabolic pathways (FTO, MC4R) that may help provide context for how your body responds to GLP-1 agonists like tirzepatide
PlexusDx is not affiliated with Eden or the manufacturer of Ozempic and has no commercial relationship with the companies reviewed
(Source: Applied Clinical Trials, 2026) Weight Loss Progress Over Time STEP-1 Trial Related at GoalBMI Wellness Semaglutide & Cardiovascular Health SELECT Trial Data Beyond weight loss, the 2023 SELECT (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity) trial established semaglutide as a cardiovascular medication a landmark finding that expanded its clinical use far beyond obesity treatment
Denmark Preclinical studies have demonstrated that FOXO4-DRI can improve tissue regeneration, enhance organ function, and extend lifespan in animal models
Addressing underlying metabolic or hormonal imbalances may unlock semaglutide's full potential
US$ 25.66
US$ 22.47
US$ 26.82
US$ 25.41
US$ 29.89
US$ 28.32
